In renal cell carcinoma, metastatic disease is characterised by significantly higher plasma concentrations of both latent and active TGF-β1 than localised tumours, and TGF-β1 drives adhesion and extracellular matrix-remodelling gene programmes associated with poor prognosis [31,32]. The gene discussed is TGFB1; the disease is renal cell carcinoma.